Research  >  Research  >  Research programs  >  Odette Cancer Research  >  Scientists
PAGE
MENU

Scientist profiles A-F

Photo of Julie Hallet
Julie Hallet, MD, M.Sc., FRCSC

Associate scientist

Sunnybrook Health Sciences Centre
2075 Bayview Ave., Room T2 63
Toronto, ON
M4N 3M5

Phone: 416-480-6100 ext. 64774
Fax: 416-480-6002

Administrative Assistant: Cyril Manahan
Phone: 416-480-4774
Email: cyril.manahan@sunnybrook.ca

Referrals: Please fax to 416-480- 6002

Education:

  • MD, 2006, Université Laval, Canada
  • Specialty training, 2011, general surgery, Université Laval, Canada
  • M.Sc., clinical epidemiology, Université Laval, Canada
  • Fellowship training, 2014, surgical oncology, University of Toronto, Canada
  • Advanced training, 2014, minimally invasive surgery, Institute of Research Against Digestive Cancer, Institute of Image-Guided Minimally Invasive Surgery, Institut Hospitalier Universitaire de Strasbourg, France

Appointments and Affiliations:

  • Associate scientist, Evaluative Clinical Sciences, Odette Cancer Research Program, Sunnybrook Research Institute
  • Associate professor, department of surgery & IHPME, U of T
  • Surgical oncologist, Sunnybrook Health Sciences Centre
  • Adjunct scientist, Institute of Evaluative Clinical Sciences (ICES)

Clinical Expertise:

  • Hepatobiliary, pancreatic and gastrointestinal malignancies
  • Neuroendocrine tumours

Research Foci:

  • Health services research
  • Quality monitoring, processes of care and outcomes in cancer care
  • Patient-centred and patient-reported outcomes
  • Patient and service users engagement in research

Research Summary:

Dr. Hallet’s research focuses on clinical outcomes in cancer care, mostly using health services research. She focuses area of cancer care where better definition of outcomes is needed to support the delivery of cancer care, where understanding of patient-centred care is necessary to design enhanced care pathways and quality metrics, and where access to care may impact outcomes. This includes examinations of care utilization, novel patient-centred outcomes, and clinical teams organization. This work is grounded in patient engagement and input through the entire research process, as well as equity through the research and care process. Dr Hallet’s has been supported by over $10 millions in peer-review operating grants and led to over 200 peer-reviewed publications.

Selected Publications:

See current publications list at PubMed.

  1. Hallet J, Sutradhar R, Flexman A, McIsaac DI, Carrier FM, Turgeon AF, McCartney C, Chan WC, Coburn N, Eskander A, Jerath A, Perez d’Empaire P, Lorello G. The association between anesthesiology-surgery teams sex-diversity and major morbidity BJS. 2024; 111(5).
  2. Hallet J, Sutradhar R, Jerath A, Perez d’Empaire P, Carrier F, Turgeon A, McIsaac DI, Idestrup C, Lorello G, Flexman A, Kidane B, Kaliwal Y, Chan WC, Barabash V, Coburn N, Eskander A. The association between familiarity of the surgeon-anesthesiologist dyad and post-operative patient outcomes for complex gastrointestinal cancer surgery: a population-based study. JAMA Surgery. 2022;(EPub ahead of print).
  3. Hallet J, Zuckerman J, Guttman MP, Chesney T, Haas B, Mahar AL, Eskander A, Chan WC, Hsu A, Barabash V, Coburn N, for the RESTORE-C group. Patient-reported symptom burden after cancer surgery in older adults: a population-level analysis. Ann Surg Onc. 2022;[EPub ahead of print] doi: 10.1245/s10434-022-12486-0.
  4. Hallet J, Sutradhar R, Isenberg-Grzeda E, Noel CW, Mahar AL, Vigod SN, Bolton J, Deleemans J, Chan WC, Coburn NG, Eskander A, on behalf of the Enhanced Supportive Psycho-Oncology Canadian Care (ESPOC) Group. Association between patient-reported outcomes and subsequent non-fatal self-injury after a cancer diagnosis. 2022. JAMA Oncol; doi:10.1001/jamaoncol.2022.0203. Principal Author. IF 32
  5. Bateni S, Coburn NG, Law C, Singh S, Myrehaug S, Assal A, Hallet J. Incidence and predictors of second primary cancers in neuroendocrine tumors. JAMA Onc. 2021;doi:10.1001/jamaoncol.2021.4531
  6. Hallet J, Law C, Singh S, Mahar A, Myrehaug S, Zuk V, Zhao H, Assal A, Coburn N. Risk of cancer-specific death for patients diagnosed with neuroendocrine tumors: a population-based analysis. J Natl Compr Canc Netw. 2021;4:1-10.
  7. Bennett S, Coburn N, Law C, Mahar A, Zhao H, Singh S, Zuk V, Myrehaug S, Gupta V, Levy J, Hallet J. Upfront small resection for small bowel neuroendocrine tumors with synchronous metastases: a propensity-score matched comparative population-based analysis. Annals of Surgery. 2020;[EPub ahead of print] doi:10.1097/SLA.0000000000004647
  8. Chesney TR, Haas B, Coburn NG, Mahar AL, Zuk V, Zhao H, Wright FC, Hsu AT, Hallet J, for the RESTORE-C Group. Patient-centred time at home outcomes in older adults after surgical cancer treatment. JAMA Surgery. 2020;155(11):e203754

Related News and Stories: